Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 32 out of 100. End-of-life care

Topic: Risk, prevention and care in population studies

Plain-language summary

This study explored the views and experiences of Australians living with dementia relating to voluntary assisted dying (VAD) as an end-of-life care option. Semi-structured interviews were conducted online with 12 Australians living with dementia. The findings of this study identified that participants wanted VAD as an end-of-life care option to achieve improved quality of life, a good death, and to control their end-of-life care. Without this option, participants feared they are at risk of a poor dying experience, including potential abuse if they require residential care. The participants felt their living experiences of stigma and discrimination presented significant barriers to realising what they viewed as their right to VAD access. These findings highlight the importance of capturing the views of people living with dementia relating to VAD as an end-of-life care option, as without an in-depth understanding of their experiences, future end-of-life policy and practice may not reflect their end-of-life care preferences.

What this study adds

Evidence grade: Low

In interviews with 12 Australians living with dementia, participants wanted voluntary assisted dying as an end-of-life option to control their care and avoid a poor dying experience. It reports their views on end-of-life care, not a treatment or cure for Alzheimer's disease.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Matthys, A., Cash, B., & Moorhead, B. (2026). Voluntary assisted dying views and experiences of Australians living with dementia: a qualitative study. Mortality. https://doi.org/10.1080/13576275.2026.2704548

Vancouver

Matthys A, Cash B, Moorhead B. Voluntary assisted dying views and experiences of Australians living with dementia: a qualitative study. Mortality. 2026. doi:10.1080/13576275.2026.2704548.

BibTeX

@article{matthys2026-be747787,
  author  = {Matthys, Adrienne and Cash, Belinda and Moorhead, Bernadette},
  title   = {{Voluntary assisted dying views and experiences of Australians living with dementia: a qualitative study}},
  journal = {Mortality},
  year    = {2026},
  doi     = {10.1080/13576275.2026.2704548},
  url     = {https://doi.org/10.1080/13576275.2026.2704548}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

In interviews with 12 Australians living with dementia, participants wanted voluntary assisted dying as an end-of-life option to control their care and avoid a poor dying experience. It reports their views on end-of-life care, not a treatment or cure for Alzheimer's disease.

Study details

How this study scored 32/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 32 of 100.32 of 100 points earned68 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Mortality)
Journal's citation record 0 / 4 Mortality: journal h-index 54 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.5 citations a year over 2 year(s) since 2026
Impact for its field and year 3 / 6 Cited 6.4× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Bernadette Moorhead: h-index 9 (OpenAlex, whole career)
Institution's track record 0 / 3 Charles Sturt University: institution h-index 321 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 32 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in End-of-life care from nearby years

Also tagged “nursing”

995 studies in the library carry the topic tag “nursing”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 995 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on End-of-life care

See all studies in End-of-life care →